Expert Analysis

DOJ Directive Gives Contractors A Fraud Risk Road Map

For government contractors, the 10 factors described in the U.S. Department of Justice's recent corporate fraud en... (more story)

A Nuanced Reading Of DOL's Mental Health Parity Guidance

Though a recent U.S. Department of Labor bulletin may suggest that agency enforcement pressure on group health pla... (more story)

Where DOJ's Fraud Directive May Actually Affect Enforcement

The U.S. Department of Justice’s recent directive outlining corporate fraud enforcement priorities is mostly a man... (more story)

Deals & Corporate Governance More

3 Federal Circuit Clashes To Watch In November

A high-stakes case that will determine whether the U.S. government should face patent infringement claims over Moderna's COVID-19 vaccines and Labcorp's appeal of a nine-figure patent verdict against it are am... (more story)

​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of p... (more story)

NC Health Plan, Atrium Settle Spat Over Cost-Sharing Program

The North Carolina state health plan said on Tuesday that it will add Atrium Health to its list of in-network providers next year after a public showdown over the nonprofit health system's exclusion from the p... (more story)

Insurance Lobby Decries 'One-Two Punch' Of CMS Moratorium

Insurance brokers are in court fighting a CMS moratorium on new registrations for agents and brokers from entering Affordable Care Act exchanges. The businesses are also feeling the effects of canceled coverag... (more story)

3 Firms Steer Obesity Drugmaker Corxel's $377M SPAC Deal

Obesity-focused biopharmaceutical company Corxel Pharmaceuticals Inc. on Monday unveiled plans to go public by merging with special-purpose acquisition company Amanat Acquisition Corp. in a deal expected to ge... (more story)

In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth... (more story)

Digital Health & Technology More

Milliman Reaches $15.5M Deal In Life Insurance FCRA Suit

Risk management firm Milliman Inc. is set to pay $15.5 million to resolve a consumer class action accusing the company of peddling flawed information to life insurance companies, according to a proposed settle... (more story)

OpenAI Sued Over Epilepsy Death Allegedly Tied To ChatGPT

​The parents of a Chinese national with epilepsy who died earlier this year sued OpenAI on Tuesday in California state court, alleging ChatGPT was effectively practicing medicine without a license when it desi... (more story)

Full 9th Circ. Won't Review Surgical Robot Antitrust Fight

The full Ninth Circuit declined to reconsider an appellate panel's recent decision reviving a surgical repair company's antitrust suit alleging Intuitive Surgical blocked third parties from supplying parts for... (more story)

Intuitive Surgical Strikes $450M Deal In Robot Antitrust Suit

Intuitive Surgical said in its quarterly earnings report Tuesday that it reached a $450 million settlement to resolve a hospital class action alleging it monopolized the market for servicing its da Vinci surgi... (more story)

Metabase, Pediatric Telehealth Biz Sued Over Patient Info Leak

Open-source AI analytics company Metabase Inc. and pediatric telehealth provider Blueberry Medical failed to protect patients' personal health information from being exposed during a cybersecurity attack, and ... (more story)

7th Circ. Rejects Removal Of Hospital Patient Privacy Suits

The Seventh Circuit on Tuesday joined a host of other appellate courts in determining healthcare providers were not "acting under" the federal government when they created patient web portals, finding actions ... (more story)

Policy & Compliance More

BREAKING: DOL Finalizes Pharmacy Benefit Manager Fee Disclosure Rule

The U.S. Department of Labor's employee benefits arm unveiled a final rule Thursday that requires pharmacy benefit managers — which act as intermediaries between drugmakers, pharmacies and insurers — to make n... (more story)

TB Outbreak In Wash. Prisons Yields $52M Damages Verdict

Washington jurors returned a $52 million verdict in favor of 23 plaintiffs who accused the state's Department of Corrections of allowing an active tuberculosis outbreak to fester and spread to hundreds of peop... (more story)

Patients Tell Colo. Justices Hospital Defied Gender Care Order

Transgender youth patients of Children's Hospital Colorado are challenging a judge's discharge of their contempt citation against the hospital for not resuming the provision of medical gender-affirming care to... (more story)

Cruise Co. Settles Fla. Doc's Whistleblower Suit Over Billing

A Florida doctor said he reached a quick settlement with Norwegian Cruise Lines Holdings Ltd. one month after filing his lawsuit alleging he was fired for opposing the company's practice of overbilling passeng... (more story)

Pharma Co. Settles Workers' 401(k) Forfeiture Suit

Boehringer Ingelheim USA Corp. and workers who accused the pharmaceutical company of misusing forfeitures from an employee 401(k) plan have settled their federal benefits dispute, parties told a Connecticut fe... (more story)

Sanofi Settles Insulin Pen Antitrust Suit, Avoiding Trial

Sanofi-Aventis US and a group of drug wholesalers have told a Massachusetts federal judge they have reached a settlement to resolve long-running antitrust litigation alleging that the drugmaker improperly soug... (more story)